Point-of-Care Diagnostics Market Size, Trends, Companies and Forecast 2023-2028 | Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company

IMARC Group has recently released a new research study titled "Point-of-Care Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

How big is the point-of-care diagnostics market?

The global point-of-care diagnostics market size reached US$ 45.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 75.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.96% during 2023-2028.

Request for a sample report or buy full report: https://www.imarcgroup.com/point-of-care-diagnostics-market/requestsample

What is point-of-care diagnostics?

Point-of-care diagnostics (POC diagnostics) refers to medical diagnostic tests that are performed at or near the location of patients, providing quick and actionable results for immediate clinical decision-making. They are designed to be simple, portable, and user-friendly, enabling healthcare professionals to diagnose and monitor various medical conditions rapidly and efficiently. They encompass numerous methods to detect various analytes, including infectious agents, biomarkers, hormones, and genetic material, among others. They are crucial for bringing diagnostic testing closer to the patient and eliminating the need for sending samples to centralized laboratories and waiting for the results. They provide rapid results, often within minutes or hours, enabling timely decision-making and prompt initiation of treatment. They also facilitate early detection and diagnosis of diseases, allowing for better disease management and prevention of complications.

What are the growth prospects and trends in the POC diagnostics industry?

At present, the increasing demand for POC diagnostics as they conduct rapid identification of infectious agents, facilitate early containment measures and prevent the spread of diseases represents one of the crucial factors impelling the market growth. Besides this, the rising demand for rapid and accurate diagnostic testing is contributing to the growth of the market. In addition, the growing occurrence of various chronic diseases, including diabetes, thyroiditis, arthritis, and cardiovascular diseases, due to the adoption of unhealthy lifestyle habits is offering a favorable market outlook.

Apart from this, the increasing outbreaks of infectious diseases caused by novel viruses are supporting the growth of the market. Additionally, the rising popularity of personalized medicine, pharmacogenomics, companion diagnostics, and targeted therapies is strengthening the growth of the market.

Explore Full Report Description At: https://www.imarcgroup.com/point-of-care-diagnostics-market

Who are the key players operating in the industry?

The report covers the major market players including: 

• Abbott Laboratories
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• Hoffmann-La Roche AG
• Instrumentation Laboratory
• Johnson & Johnson
• Nova Biomedical Corporation
• Pts Diagnostics
• Qiagen
• Siemens
• Trinity Biotech

Market Segmentation: 

The report has segmented the market into the following categories:

Breakup by Product Type:

• Blood-Glucose Monitoring Kit
• Cardio-Metabolic Monitoring Kit
• Pregnancy and Fertility Testing Kit
• Infectious Disease Testing Kit
• Cholesterol Test Strip
• Hematology Testing Kit
• Others

Breakup by Platform:

• Lateral Flow Assays
• Dipsticks
• Microfluidics
• Molecular Diagnostics
• Immunoassays

Breakup by Prescription Mode:

• Prescription-Based Testing
• OTC Testing

Breakup by End-User:

• Professional Diagnostic Centers
• Home Care
• Research Laboratories
• Others

Breakup by Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

You Can Buy Report Directly and Get Up-To 10% Discount: https://www.imarcgroup.com/checkout?id=2113&method=1

Key Highlights of the Report:                                                    

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
Read Newsletter: https://www.linkedin.com/newsletters/industry-news-about-6929400456628637696

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.